These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2021239)

  • 21. Absence of the largest platelet-von Willebrand multimers in a patient with lactoferrin deficiency and a bleeding tendency.
    Parker RI; McKeown LP; Gallin JI; Gralnick HR
    Thromb Haemost; 1992 Mar; 67(3):320-4. PubMed ID: 1641822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adhesion of platelets to purified solid-phase von Willebrand factor: effects of wall shear rate, ADP, thrombin, and ristocetin.
    Olson JD; Zaleski A; Herrmann D; Flood PA
    J Lab Clin Med; 1989 Jul; 114(1):6-18. PubMed ID: 2786916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of cryoprecipitate and plasma on plasma von Willebrand factor multimeters and bleeding time in Doberman Pinschers with type-I von Willebrand's disease.
    Ching YN; Meyers KM; Brassard JA; Wardrop KJ
    Am J Vet Res; 1994 Jan; 55(1):102-10. PubMed ID: 8141483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cleavage of human von Willebrand factor by platelet calcium-activated protease.
    Kunicki TJ; Montgomery RR; Schullek J
    Blood; 1985 Feb; 65(2):352-6. PubMed ID: 2981585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Content and functional activity of von Willebrand factor in apheresis plasma.
    Burnouf T; Caron C; Burkhardt T; Goudemand J
    Vox Sang; 2004 Jul; 87(1):27-33. PubMed ID: 15260819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. von Willebrand factor in plasma, platelets, and selected tissues of ferrets.
    Hoogstraten-Miller S; Bellinger D; Reddick R; Read M; Sigman J; Madden V
    Lab Anim Sci; 1995 Apr; 45(2):151-9. PubMed ID: 7603015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet von Willebrand factor: comparison with plasma von Willebrand factor.
    Gralnick HR; Williams SB; McKeown LP; Krizek DM; Shafer BC; Rick ME
    Thromb Res; 1985 Jun; 38(6):623-33. PubMed ID: 3927508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of monocytes in the platelet release of von Willebrand factor.
    Giedrojć J; Krupiński K; Radziwon P; Zabicki D; Klimiuk M; Bielawiec M; Breddin HK
    Rocz Akad Med Bialymst; 1996; 41(2):463-9. PubMed ID: 9020560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet von Willebrand factor determination does not improve the diagnosis of patients with suspected Type 1 von Willebrand disease.
    Shihong I; Morris D; Konkle BA
    Haemophilia; 2009 Jan; 15(1):131-4. PubMed ID: 18976254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multimeric analysis of von Willebrand factor in megakaryocytes.
    Kupinski JM; Miller JL
    Thromb Res; 1985 Jun; 38(6):603-10. PubMed ID: 3875163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Porcine platelets contain an increased quantity of ultra-high molecular weight von Willebrand factor and numerous alpha-granular tubular structures.
    Wilbourn B; Harrison P; Lawrie A; Savariau E; Savidge G; Cramer EM
    Br J Haematol; 1993 Apr; 83(4):608-15. PubMed ID: 8518177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of factor VIII/von Willebrand factor concentrates using a modified method of von Willebrand factor multimer analysis.
    Metzner HJ; Hermentin P; Cuesta-Linker T; Langner S; Müller HG; Friedebold J
    Haemophilia; 1998; 4 Suppl 3():25-32. PubMed ID: 10028315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence of selective packaging and different α-granule subtypes in canine platelets.
    Curotto S; Lunsford K; Smith W; Thomason J; Bulla C
    J Comp Pathol; 2012 Nov; 147(4):499-502. PubMed ID: 22516083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. von Willebrand factor, clotting factors, and clotting inhibitors in apheresis platelet concentrates.
    Weiss DR; Franke D; Strasser EF; Ringwald J; Zimmermann R; Eckstein R
    Transfusion; 2014 Mar; 54(3):633-9. PubMed ID: 23789907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet von Willebrand factor assay: results using two methods for platelet lysis.
    Rodeghiero F; Castaman GC; Tosetto A; Lattuada A; Mannucci PM
    Thromb Res; 1990 Jul; 59(2):259-67. PubMed ID: 2237811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Organization of von Willebrand factor on surface-activated platelets.
    Escolar G; White JG
    Arterioscler Thromb; 1993 Dec; 13(12):1852-8. PubMed ID: 8241107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Von Willebrand factor availability in platelet concentrates stored for 5 days.
    Cesar JM; García-Avello A; Monteagudo J; Espinosa JI; Lodos JC; Castillo R; Navarro JL
    Am J Hematol; 1994 Feb; 45(2):109-11. PubMed ID: 8141116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of von Willebrand factor multimers using a commercially available enhanced chemiluminescence kit.
    Cumming AM; Wensley RT
    J Clin Pathol; 1993 May; 46(5):470-3. PubMed ID: 8320330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endothelial cell synthesis of von Willebrand antigen II, von Willebrand factor, and von Willebrand factor/von Willebrand antigen II complex.
    McCarroll DR; Levin EG; Montgomery RR
    J Clin Invest; 1985 Apr; 75(4):1089-95. PubMed ID: 3872883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significance and quantitative analysis of von Willebrand factor in human platelets.
    Eller T; Brauer P; Albert J; Mayer J; Keller F
    Thromb Res; 1992 Mar; 65(4-5):631-40. PubMed ID: 1615500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.